Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen Gas May Reduce Eye Damage in Mice with Oxygen-Induced Retinopathy

Molecular hydrogen promotes retinal vascular regeneration and attenuates neovascularization and neuroglial dysfunction in oxygen-induced retinopathy mice

Research hubs: Eyes & Vision System · Brain & Nervous System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Molecular hydrogen promotes retinal vascular regeneration and attenuates neovascularization and neuroglial dysfunction in oxygen-induced retinopathy mice
Evidence type
Animal study (mouse)
Authors
Yatu Guo, Jiahui Qin, Ruiqiang Sun, Peng Hao, Zhixin Jiang, Yuchuan Wang, Zhiqi Gao, Huan Zhang, Keliang Xie, Wei Zhang
Journal
Biological Research
Year
2024
Study Type
Mouse
Delivery
Gas
Dose
3-4% hydrogen gas inhalation at different stages during oxygen-induced retinopathy protocol
H₂ concentration
3-4% H2 gas
Duration
5 days
Outcome
Positive
Peer Reviewed
Yes
Cited by
17 (OpenAlex, as of November 2026)
Country
China

TL;DR

Inhaling hydrogen gas helps reduce damage and improve healing in the eyes of mice with a disease similar to one that causes blindness in premature babies, without affecting normal eye development.

Key Finding

Inhaling 3-4% hydrogen gas promoted normal retinal blood vessel regeneration while suppressing abnormal blood vessel growth and protecting eye support cells in mice with oxygen-induced retinopathy.

Summary

This study examined whether inhaling molecular hydrogen gas could help treat retinopathy of prematurity (ROP), a serious eye disease in premature infants that can cause blindness. Researchers exposed newborn mice to high oxygen levels to mimic ROP, then gave some mice hydrogen gas to breathe. The hydrogen treatment helped restore normal blood vessel growth in the retina while reducing abnormal blood vessel growth and protecting supporting cells in the eye, likely by reducing harmful molecules called free radicals.

Practical Takeaway

This is early-stage research conducted only in mice, not humans. While the results are promising and suggest hydrogen inhalation may eventually help treat retinopathy of prematurity, much more research—including human clinical trials—would be needed before this could become a treatment option. Parents of premature infants should continue following current medical recommendations and discuss any interest in hydrogen therapy with their eye specialist.

Abstract (excerpt)

Abstract Background Retinopathy of Prematurity (ROP) is a proliferative retinal vascular disease occurring in the retina of premature infants and is the main cause of childhood blindness. Nowadays anti-VEGF and retinal photocoagulation are mainstream treatments for ROP, but they develop a variety…

Read the full abstract on PubMed